image

ISSN: 1935-1232 (P)

ISSN: 1941-2010 (E)

image
image

Mini Review - Clinical Schizophrenia & Related Psychoses ( 2024) Volume 18, Issue 1

Factor Structure of Posttraumatic Stress Disorder (PTSD) in Persons with Serious Mental Illness
Weili Lu1*, Kim T Mueser2, Yuane Jia1, Philip T Yanos3, Amanda Siriram1, Deanna Bullock1, Ke Wang1, Steven M Silverstein4, Jennifer Gottlieb5, Krista Rogers3, Pouya G Aftab1 and Stanley D Rosenberg6
 
1Department of Psychiatric Rehabilitation and Counseling Professions, Rutgers Univeristy, New Jersey, USA
2Department of Psychiatric Rehabilitation, Boston University, Boston, USA
3Department of Psychology, City University of New York, New York, USA
4Department of Psychiatry, University of Rochester Medical Center, New York, USA
5Department of Psychiatry, Harvard Medical School, Boston, USA
6Department of Psychiatry, Dartmouth Geisel School of Medicine, New Hampshire, USA
 
*Corresponding Author:
Weili Lu, Department of Psychiatric Rehabilitation and Counseling Professions, Rutgers Univeristy, New Jersey, USA, Email: luwe1@shp.rutgers.edu

Received: 18-Jun-2024, Manuscript No. CSRP-24-139292; Editor assigned: 21-Jun-2024, Pre QC No. CSRP-24-139292 (PQ); Reviewed: 08-Jul-2024, QC No. CSRP-24-139292; Revised: 16-Jul-2024, Manuscript No. CSRP-24-139292 (R); Published: 24-Jul-2024, DOI: 10.3371/CSRP.AMOS.100626

Abstract

Posttraumatic Stress Disorder (PTSD) is highly prevalent and contributes to worsened impairment among individuals with serious mental illness (SMI; e.g., schizophrenia, schizoaffective disorder, bipolar disorder, treatment refractory major depressive disorder). However, previous research has not examined the factor structure of PTSD symptoms in SMI populations. This review summarizes a published article evaluating the factor structure of PCL in two large SMI samples (N=11425; n=842 in study 1, n=583 in study 2). The latest edition of the DSM-5 4-aspect framework was shown to be the most appropriate one for PTSD amongst individuals suffering from SMI, exhibiting consistent measurement results across ethnic background, classifications of diagnosis, and generations. The review further discusses the suitability of DSM-5 4-factor model of PTSD among people with SMI, as well as future directions for PTSD research among this population.

Keywords

PTSD • Serious Mental Illness (SMI) • Factor structure • PTSD checklist • Trauma assessment • Schizophrenia

Abbreviations

SABIC: Sample Size Adjusted Bayesian Information Criterion; TLI: Tucker Lewis Index; CFI: Comparative Fit Index; SRMR: Standardized Root Mean Square Residual; RMSEA: Root-Mean Square Error of Approximation

Introduction

Research has supported the high prevalence of comorbid Posttraumatic Stress Disorder (PTSD) in person with serious mental illnesses (SMI, i.e., schizophrenia, bipolar disorder, and treatment refractory Major Depressive Disorder (MDD) [1]. For example, one review found that PTSD prevalence rates in schizophrenia ranged between 20%-30% [2]. Previous studies have also highlighted the association with Adverse Childhood Experiences (ACEs) with SMI development, as well as increased rates of comorbid PTSD among individuals with SMI compared to the general population.

Symptoms of PTSD could be hidden or under-detected in SMI due to SMI-associated illnesses and deficits. Identification of schizophrenia/ schizoaffective illness or bipolar disorder contributed to lower PTSD record preservation [3]. Examples of barriers in recognizing PTSD symptoms in SMI include distinguishing between paranoid delusions in psychosis from the chronic mistrust common in PTSD, or distinguishing between mania symptoms such as irritability, risk-taking behaviours, and decreased need for sleep from anger outbursts, reckless or self-destructive behaviours, and sleep difficulties in PTSD. Considering the difficulty in diagnosing signs of PTSD in people with SMI, physicians should adopt PTSD screening techniques for patients in order to improve identification. To educate the medical community, it is vital to investigate the PCL component architecture among people with SMI.

The PTSD Checklist is commonly used as a PSTD screening measure [4]. The factor structure of the PCL has been assessed by various Confirmatory Factor Analyses (CFAs) in non-SMI samples such as veterans, college students, substance dependent clients and firefighters. Six of the eleven investigations accepted Elhai's 5-factor Dysphoric Arousal as the greatest match, three accepted King's Diagnostic and Statistical Manual of Mental Disorders (DSM-5) 4-factor model as the second best fit, and two supported Simms' 5-factor Dysphoria model. The DSM-IV 3-factor model includes re-experiencing, avoidance and over-arousal; the King's 4-factor Numbing model (aka DSM-5 model) involves all three of those variables in the inclusion of alleviating factor; the Simms' 4-factor Dysphoria model also incorporates those three factors with the addition of dysphoria; the DSM-5 4-factor model proposed symptom clusters of re-experiencing, avoidance, negative cognitions/mood, and over-arousal; Elhai's 5-factor model suggested factor. However, these previous CFA studies have not examined the factor structure of the Posttraumatic Checklist (PCL) utilizing a large SMI sample, which could be informative both clinically and for research.

Literature Review

This review summarizes a published article evaluating the factor structure of PTSD symptoms measured with the PCL in two large samples of people with SMI (n=842 in study 1, n=583 in study 2) [5]. It investigated whether the PCL factor structure in the SMI population is similar to the factor structures reported in other populations [6]. One previous study, using the PCL with a veteran sample, supported Elhai’s 5-factor and DSM-5 4-factor models, while another study, using the PTSD Checklist for the DSM-5 (PCL-5) with an SMI sample, supported the DSM-5 4-factor model and the 7-factor model of PTSD [7]. Based on earlier findings from 10 reviewed studies, the hypothesis anticipated that the DSM-5 4-factor model would have the best fit, while Elhai’s 5-factor, Simms’ Dysphoria 4-factor, and the DSM-IV 3-factor models would each have adequate fit [5].

Participants in Study 1 were drawn from a larger investigation of patients with SMI receiving treatment through public mental health systems in four U.S. states. Among the 1114 people in the larger study, 842 participants had PCL data. Of these, 50.8% had schizophrenia, 21.7% had schizoaffective disorder, 25.3% had bipolar disorder, and 8.3% had recurrent MDD. Study 2 included data from 583 participants with SMI diagnoses who were screened for PTSD in a large public mental health outpatient system in the US. The breakdown of participants was as follows: 11.1% had schizophrenia, 20.6% had schizoaffective disorder, 34.7% had bipolar disorder, and 33.9% had major MDD [5]. All participants met the state criteria for SMI. Participants in both studies were racially and ethnically diverse (45.7% African American; 40.6% Caucasian; 6.5% Hispanic; 3.5% American Indian; 0.6% Asian; 3.1% other) (Table 1).

Table 1. Demographics and clinical characteristics of participants (N=1425).

Demographics/Clinical characteristics Study 1-5 Site (n=842)   Study
2-NJ
(n=583)
  Total
(N=1425)
     

Gender

n % n % n % χ2 107 P <0.001

Male

310 63 206 35.3 738 51.8    

Female

310 37 377 64.7 687 48.2    

Race/Ethnicity

3.94

<0.001

African American

388 46 262 44.9 650 45.7    

Caucasian

379 45 199 34.1 578 40.6    

Hispanic

24 2.9 68 11.7 92 7    

American Indian

49 5.8 1 0.2 50 4    

Asian

0 0 8 1 8 1    

Other

0 0 44 8 44 3    

Missing

0 0 1 0 1 0    

Married

4

0

Yes

93 11 46 8 139 9.8    

No

746 89 536 91.9 1282 90    

Missing

3 0.4 1 0 4 0    

Education

            37.06 <0.001

Less than HS

310 37 153 463 463 32.5    

HS

242 29 28.7 42.2 488 34.2    

Beyond HS

285 34 173 29.7 458 32.1    

Missing

5 0.6 11 2 16 1    

Primary diagnosis

363.49

<0.001

Schizophrenia

428 51 65 11.1 493 34.6    

Schizoaffective

183 22 120 20.6 303 21.3    

Bipolar I without psychotic

45 13 92 6.0 200 14.0    

Bipolar I with psychotic

45 5.3 35 6 80 6    

Bipolar II

6 0.7 33 6 39 3    

Bipolar NOS

2 0.2 42 7 44 3    

MDD recur. w/o psychotic

49 5.8 150 25.7 199 14.0    

MDD recur. w/ psychotic

21 2.5 46 8 67 5    

Secondary diagnosis

547.71

<0.001

Borderline personality disorder

7 0.8 22 7 29 3    

PTSD

14 1.7 51 16 65 6    

Substance use disorder

99 12 89 27.9 188 16.3    

Alcohol use disorder

143 17 56 17.6 199 17.2    

Personality disorder other than BPD

19 2.3 9 3 28 2    

PCL

234.10

<0.001

< 45

533 63 129 22.2 662 46.5    

> 45

309 37 453 77.8 762 53.5    

 

M SD M SD M SD t P

Age*

41.93 10 41 11.36 41.53 10.60 2 0.1

PCL sum

39.11 16 55 16.59 45.75 18.1 -18.4 <0.001

There were also notable differences among participants. In terms of gender, Study 1 had a large percentage (63.2%) of men compared to Study 2 (35.3%). Moreover, schizophrenia/schizoaffective disorder was more common than mood disorders in Study 1 (72.5% vs 27.5%), while mood disorders were more common than schizophrenia/schizoaffective disorder in Study 2 (31.7% vs 69.3%). Finally, while PTSD levels varied among participants in Study 1, 78% of participants in Study 2 had a PCL score of 45 or higher, indicating probable PTSD. CFAs were conducted with Mplus 8.7 to assess how well the four models fit the data across the combined sample, the Study 1 sample, study 2 sample and schizophrenia, bipolar, and MDD samples separately (Table 2) [5].

Table 2. Model fit indices for independent samples.

â?¯ Total Sample (N=1425)

 

χ2

 

df

 

χ2/df

 

P

 

CFI

 

TLI

 

RMSEA

 

SRMR

 

SABIC

 

DSM IV 3-factor

 

643.390

 

116

 

5.546

 

<0.001

 

0.961

 

0.954

 

0.056

 

0.030

 

75204.426

 

DSM-5 4-factor

 

452.280

 

113

 

4.002

 

<0.001

 

0.975

 

0.970

 

0.046

 

0.022

 

75025.570

 

Simms 4-factor

 

459.216

 

113

 

4.064

 

<0.001

 

0.974

 

0.969

 

0.046

 

0.022

 

75032.511

 

Elhai 5-factor

 

448.507

 

109

 

4.115

 

<0.001

 

0.975

 

0.968

 

0.047

 

0.022

 

75038.143

 

Note: Model fit for total sample (N=1425): DSM5> Simms> 5-factor> 3-factor.

 

Study 1
(5-Site, n=842)

 

                 
DSM IV 3-factor

 

402.439

 

116

 

3.469

 

<0.001

 

0.958

 

0.950

 

0.054

 

0.031

 

43123.073

 

DSM-5 4-factor

 

289.873

 

113

 

2.565

 

<0.001

 

0.974

 

0.969

 

0.043

 

0.024

 

43021.188

 

Simms 4-factor

 

289.087

 

113

 

2.558

 

<0.001

 

0.974

 

0.969

 

0.043

 

0.024

 

43020.401

 

Elhai 5-factor

 

model inadmissible; correlation>1 between two factors (anxious and dysphoric arousal)

 

Note: Model fit for study 1 sample (5-Site, n=842): DSM5 ≈ Simms> 3-factor> 5-factor.

 

Study
2 (NJ, n=583)

 

                 
DSM IV 3-factor

 

452.268

 

116

 

3.899

 

<0.001

 

0.930

 

0.918

 

0.071

 

0.044

 

31164.165

 

DSM-5 4-factor

 

356.162

 

113

 

3.152

 

<0.001

 

0.949

 

0.939

 

0.061

 

0.034

 

31077.640

 

Simms 4-factor

 

358.936

 

113

 

3.176

 

<0.001

 

0.949

 

0.938

 

0.061

 

0.033

 

31080.414

 

Elhai 5-factor

 

352.633

 

109

 

3.235

 

<0.001

 

0.949

 

0.937

 

0.062

 

0.033

 

31086.885

 

Note: Model fit for study 2 sample (NJ, n=583): DSM5>Simms>5-factor>3-factor.

 

Schizophrenia
(n= 796)

 

                 
DSM IV 3-factor

 

461.689

 

116

 

3.980

 

<0.001

 

0.949

 

0.941

 

0.061

 

0.034

 

41162.892

 

DSM-5 4-factor

 

320.055

 

113

 

2.832

 

<0.001

 

0.970

 

0.964

 

0.048

 

0.025

 

41031.771

 

Simms 4-factor

 

323.692

 

113

 

2.865

 

<0.001

 

0.969

 

0.963

 

0.048

 

0.025

 

41035.307

 

Elhai 5-factor

 

model inadmissible; correlation >1 between two factors (anxious arousal with dysphoric arousal)

 

Note: Model fit for schizophrenia sample (n=796): DSM5>Simms>3-factor>5-factor.

 

Bipolar
(n=363)

 

                 
DSM IV 3-factor

 

244.535

 

116

 

2.108

 

<0.001

 

0.960

 

0.953

 

0.055

 

0.037

 

19745.545

 

DSM-5 4-factor

 

203.305

 

113

 

1.799

 

<0.001

 

0.972

 

0.966

 

0.047

 

0.034

 

19712.480

 

Simms 4-factor

 

215.113

 

113

 

1.904

 

<0.001

 

0.968

 

0.962

 

0.050

 

0.034

 

19724.288

 

Elhai 5-factor

 

202.192

 

109

 

1.855

 

<0.001

 

0.971

 

0.964

 

0.049

 

0.034

 

19722.255

 

Note: Model fit for bipolar sample (n=363): DSM5> 5-factor> Simms> 3 factor.

 

MDD
(n=266)

 

                 
DSM IV
3-factor

 

316.611

 

116

 

2.729

 

<0.001

 

0.922

 

0.908

 

0.081

 

0.050

 

13447.810

 

DSM-5 4-factor

 

236.466

 

113

 

2.093

 

<0.001

 

0.952

 

0.942

 

0.064

 

0.039

 

13374.904

 

Simms 4-factor

 

220.519

 

113

 

1.951

 

<0.001

 

0.958

 

0.950

 

0.060

 

0.037

 

13358.957

 

Elhai 5-factor

 

model inadmissible; correlation>1 between two factors (anxious arousal with dysphoric arousal)

 

Note: Model fit for MDD sample (n=266): Simms> DSM5> 3-factor> 5-factor.

 

Multiple indicators were used to assess the model's quality of fit. The outcomes somewhat confirmed the hypothesis. The findings showed that while the DSM-5 4-factor model had the best overall fit, the Simms’ model was the next best fit. The results did not support Elhai’s 5-factor model, which displayed a poor fit for data in the schizophrenia sample, the MDD sample, and the Study 1 sample. It was noted, upon comparison fit indices across the various samples, that the DSM-5 model performed well compared to the DSM-IV and the Simms models. Furthermore, while PTSD symptoms in the overall SMI sample, and the schizophrenia and bipolar samples were best explained by DSM-5 4-factor model, Simms’s model did perform better in the MDD sample than the DSM-5 model, which suggests a need for further research focused on PCL for individuals with MDD.

Measurement invariance was evaluated using multi-group CFA across various groups: psychotic vs. nonpsychotic, gender (male vs. female), race (white vs. black), age (18-35 vs. 35+), and diagnostic categories (schizophrenia/schizoaffective vs. bipolar vs. MDD) for the best fitting DSM-5 model (Table 2). Among psychotic and nonpsychotic groups, the DSM-5 4-factor model showed configure uniformity and high fit. The DSM-5 4-factor model showed outstanding match among genders and ethnicities.

The factor loadings and inter correlations of the DSM-5 4-factor model across the total sample and each diagnostic group (Figure 1). Most items strongly fit their assigned factors, with loadings ranging from 0.70 to 0.86. However, three items-C3 (numbing), D1 (hypervigilance), and D4 (hypervigilance) exhibited weaker loadings, between 0.52 and 0.68. The inter correlations among the four factors showed acceptable to excellent fit for most groups. Additionally, the reliability of the intrusion, avoidance, numbing and hypervigilance subscales was acceptable to excellent for both the total sample and the diagnostic groups.

clinical-related-major

Figure 1. Factor pattern matrix and inter-factor correlation of DSM-5 4-factor model of PTSD for total sample (n=1425), schizophrenia/schizoaffective (n=796), bipolar disorder (n=363) and major depressive disorder (n=266). Note: Factor loadings and inter-factor-correlations are listed in the order of total sample/schizophrenia-schizoaffective/bipolar/major depressive disorder. Sample; CFI=0.97, 0.97, 0.97, 0.95 respectively.

Discussion

CFA was used to evaluate the fit of four PTSD models described in the prior literature in two distinct sets of people with SMI. These findings differ where the sample consisted of participants from the Million Veteran Program (MVP), which found that Elhai’s 5-factor model was the best fit model instead of the DSM-5 4-factor model [6]. In this study involving SMI populations, Elhai’s 5-factor model was inadmissible with the Study 1 sample, schizophrenia sample, and MDD sample, and did not achieve convergence. While [6] utilized veterans from all branches of the U.S. military, the current study focused on individuals with severe psychopathology and severe functional impairment due to SMI. However, findings are consistent with the evaluation of PTSD factor structure in SMI population using the PCL-5 [7] which supported the DSM-5 model.

Limitations from the present study should be noted. Data collected were from individuals with SMI receiving treatment through public mental health systems including community mental health centres and state psychiatric hospitals, thus findings may not generalize to other treatment settings or to those not in treatment. While the focus on the PCL for DSM-IV rather than the more updated PCL-5 for DSM-5 allowed for direct comparison with existing research of the factor structure of PTSD, It additionally excluded the study of the PCL-5's newer notion of PTS [8].

Conclusion

The findings support the use of DSM-5 model of PTSD among individuals with SMI, suggesting that similar diagnostic algorithms can be used for detecting and assessing PTSD in the SMI population. To gain a deeper and more current understanding of PTSD in individuals with SMI, future research should utilize the PCL-5 and incorporate clinician interviews, such as the Clinician Administered PTSD Scale for DSM-5 to evaluate the latest models of PTSD and examine the factor structure of PTSD among SMI populations. Future studies should further evaluate the utility of Elhai's 5-factor model among individuals with SMI, as well as examine the PTSD factor models in people with MDD and co-occurring PTSD. PTSD assessment leads to increased PTSD detection among individuals with SMI, which is essential for providing trauma-informed treatment access for this underserved population.

References

Citation: Lu, Weili, Kim T Mueser, Philip T Yanos and Amanda Siriram, et al. "Factor Structure of Posttraumatic Stress Disorder (PTSD) in Persons with Serious Mental Illness." Clin Schizophr Relat Psychoses 18 (2024). DOI: 10.3371/CSRP.AMOS.100626

Copyright: © 2024 Lu W, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.